~~<i id='DC77DB2846'><strike id='DC77DB2846'><tt id='DC77DB2846'><pre id='DC77DB2846'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：explore 2025-09-30 17:03:23 - browse：75399

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： FDA approves world's first CRISPR

focus

knowledge

leisure time

Wikipedia

knowledge

AdobeOliverMcGowanwas18yearsoldwhenhewashospitalizedinEnglandwithrecurrentseizuresandpneumonia.Hewas

WSS

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

How to save health care price transparency rules

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Radiology is caught between AI's potential and concern for patients

AI models in health care face new federal disclosure requirements

UCLA team creates talking throat patch for voice disorders

leisure time

hotspot

focus

After affirmative action ruling, medical educators look to 'holistic review'

What causes an itch? Researchers may have solved the mystery

Trump demands the U.S. pay no more for drugs than other countries … again

Radiology is caught between AI's potential and concern for patients

Medical records are filled with copy

Roche to buy Carmot Therapeutics, developer of obesity drugs

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What PEPFAR has meant on the ground in Ukraine

Tori Bowie and the unacceptable rates of Black maternal death

How to save health care price transparency rules

knowledge

HHS secretary Becerra pressed on Change HealthCare cyberattack

Steward Health Care Massachusetts hospitals face fiscal disaster

Radiology is caught between AI's potential and concern for patients

The woman behind the Dana Farber

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Why depression after traumatic brain injury is distinct

leisure time

leisure time

Wikipedia

knowledge